Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BrightPath Biotherapeutics Co.Ltd. (JP:4594)
TSE/TYO:4594
Holding JP:4594?
Track your performance easily
4594 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥41.00 - ¥100.00
Previous Close¥56
Volume1.76M
Average Volume (3M)863.04K
Market Cap
¥4.78B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.58
Next Earnings
Feb 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-16.63
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume863,042
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
4594 FAQ
What was BrightPath Biotherapeutics Co.Ltd.’s price range in the past 12 months?
BrightPath Biotherapeutics Co.Ltd. lowest stock price was ¥41.00 and its highest was ¥100.00 in the past 12 months.
What is BrightPath Biotherapeutics Co.Ltd.’s market cap?
Currently, no data Available
When is BrightPath Biotherapeutics Co.Ltd.’s upcoming earnings report date?
BrightPath Biotherapeutics Co.Ltd.’s upcoming earnings report date is Feb 07, 2025 which is in 73 days.
How were BrightPath Biotherapeutics Co.Ltd.’s earnings last quarter?
BrightPath Biotherapeutics Co.Ltd. released its earnings results on Nov 08, 2024. The company reported -¥2.486 earnings per share for the quarter, missing the consensus estimate of N/A by -¥2.486.
Is BrightPath Biotherapeutics Co.Ltd. overvalued?
According to Wall Street analysts BrightPath Biotherapeutics Co.Ltd.’s price is currently Overvalued.
Does BrightPath Biotherapeutics Co.Ltd. pay dividends?
BrightPath Biotherapeutics Co.Ltd. does not currently pay dividends.
What is BrightPath Biotherapeutics Co.Ltd.’s EPS estimate?
BrightPath Biotherapeutics Co.Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BrightPath Biotherapeutics Co.Ltd. have?
BrightPath Biotherapeutics Co.Ltd. has 85,291,300 shares outstanding.
What happened to BrightPath Biotherapeutics Co.Ltd.’s price movement after its last earnings report?
BrightPath Biotherapeutics Co.Ltd. reported an EPS of -¥2.486 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.041%.
Which hedge fund is a major shareholder of BrightPath Biotherapeutics Co.Ltd.?
Currently, no hedge funds are holding shares in JP:4594
---
BrightPath Biotherapeutics Co.Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technical Analysis
I'rom Group Co., Ltd.
―
DNA Chip Research Inc.
―
Chiome Bioscience Inc.
―
Delta-Fly Pharma, Inc.
―
---